Mesco Pharmaceuticals Ltd - MESCO PHARMA Share Price

Sector: Pharmaceuticals | ISIN: INE839X01015
₹ 4.54 (4.85%) icon10 Jan, 2022, 3:57:12 PM

Mesco Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 1/10/2022 3:57:12 PM

    ₹ 4.54 0.21 4.85
  • Open
  • ₹ 4.54
  • Prev. Close
  • ₹ 4.33
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 4.54
  • Day's Low
  • ₹ 4.54
  • 52 Week's High
  • ₹ 0
  • 52 Week's Low
  • ₹ 0
  • Book Value
  • ₹ -5.136
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 9.23
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Mesco Pharmaceuticals Ltd Corporate Actions

No Record Found


Mesco Pharmaceuticals Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Mesco Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
30 April , 2024 | 06:55 PM

PROMOTER - TOTAL39.30%

Indian: 39.30%

Foreign: 0%

NON-PROMOTER - TOTAL 60.70%

Institutions: 0.00%

Non-Institutions: 60.70%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Mesco Pharmaceuticals Ltd FINANCIALS

No Data Available To Display Chart

Mesco Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Mesco Pharmaceuticals Ltd

  • Dushyant Kumar Singh
  • Director
  • N S Parameshwaran
  • Company Secretary
  • Hawa Singh Chahar
  • Independent Director
  • Dhruv Singh
  • Director & Chief Executive Off

Summary

Mesco Pharmaceuticals started commercial operations in Jun.91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations. It set up a formulation plant to manufacture injectables, syrups, ointments and tablets/capsules. The company in technical partnership with Merz, Germany, introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively. It is now developing drugs for cardio-vascular diseases and Parkinsons disease. Apart from Merz, Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation.The company has expanded its marketing network to the CIS, Italy, Germany and Africa. It is setting up a multi-purpose bulk drug plant with sterile technology to manufacture the latest bulk drugs, in technical collaboration with Chementechno, Austria.During 1996-97, the company earned foreign exchange worth Rs 1.25... Read More


Reports by Mesco Pharmaceuticals Ltd


Reports by Mesco Pharmaceuticals Ltd

Company FAQ

No Record Found